intestinal cancer: A malignant neoplasm involving the intestine
Benign neoplasm: Other and unspecified parts of small intestine
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_SMALL_INTESTINE_OTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
556 |
4. Check minimum number of eventsNone |
556 |
5. Include endpointsNone |
556 |
6. Filter based on genotype QC (FinnGen only) |
556 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum partis aliae sive non specificatae intestini
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Other and unspecified parts of small intestine
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Other and unspecified parts of small intestine
- Benign neoplasm: Small intestine
- Benign neoplasm: Small intestine
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3252 | 1858 | 1376 |
| Only index persons | 2890 | 1708 | 1182 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.04 |
| Only index persons | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 62.51 | 61.87 | 63.38 |
| Only index persons | 61.66 | 61.29 | 62.20 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 556 | 344 | 212 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | 60.31 | 58.29 | 63.59 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 507
- Matched controls
- 5067
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
4503599627370496.0
323.0
480
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
12.6
142.1
387
1030
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
52.2
47.1
56
12
Z71.9
ICD-10 Finland
Counselling, unspecified
8.4
42.7
100
144
SPAT1236
SPAT
Informing family of child’s disability
14.8
41.6
71
55
UJF32
NOMESCO Finland
Coloscopy
3.7
38.3
233
957
Z51.88
ICD-10 Finland
Other specified medical care
17.3
37.6
60
39
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
13.9
37.2
65
53
Z26.9
ICD-10 Finland
Need for immunization against unspecified infectious disease
19.2
34.0
52
30
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
18.1
32.7
51
31
Z50.1
ICD-10 Finland
Other physical therapy
7.1
32.6
84
137
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
7.3
29.1
73
114
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
36.1
29.1
37
11
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
5.0
28.6
101
242
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.9
26.9
245
1248
WZC30
SPAT
NA
12.2
26.7
49
44
UJF92
NOMESCO Finland
Capsular endoscopy
10.7
25.1
49
50
JFB00
NOMESCO Finland
Partial resection of small intestine
13.3
25.1
44
36
Z01.7
ICD-10 Finland
Laboratory examination
4.1
25.0
109
319
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
24.1
163
673
Z01.3
ICD-10 Finland
Examination of blood pressure
15.7
23.3
38
26
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
21.3
23.3
34
17
UJF30
NOMESCO Finland
Ileoscopy through colon
4.1
22.8
96
271
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.0
22.5
97
280
Z25.1
ICD-10 Finland
Need for immunization against influenza
5.4
22.2
70
146
Z12.3
ICD-10 Finland
Special screening examination for neoplasm of breast
21.9
21.5
31
15
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
52.4
21.3
25
5
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
3.7
21.1
100
312
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.4
20.3
78
201
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
13.3
20.2
35
28
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
37.4
20.0
25
7
XFE00
NOMESCO Finland
Epicardial ultrasonography
7.7
19.2
45
63
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
35.9
19.1
24
7
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.3
18.9
74
194
UJF02
NOMESCO Finland
Peroral enteroscopy
24.8
18.8
26
11
A02BC05
ATC
esomeprazole; systemic
2.3
18.0
262
1603
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.7
17.0
59
137
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
16.5
138
628
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
15.6
92
335
ZX120
NOMESCO Finland
Intravenous
3.5
15.5
78
253
Z2221
NOMESCO Finland
Medical doctor
2.3
14.9
180
984
SPAT1285
SPAT
Provision of consultation response
4.2
14.3
56
146
A02BC01
ATC
omeprazole; systemic
2.2
14.2
188
1067
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
14.1
87
324
OAB50
SPAT
NA
10.9
13.9
26
25
A02BA02
ATC
ranitidine; systemic
2.4
13.9
140
695
A02BC02
ATC
pantoprazole; systemic
2.1
13.7
363
2746
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.6
13.5
39
74
Z3231
NOMESCO Finland
Registered nurse
2.2
13.4
174
974
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
13.1
83
316
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.6
13.0
45
104
107
Kela drug reimbursment
Pernicious anaemia
7.8
12.9
29
39
B03BA03
ATC
hydroxocobalamin; parenteral
3.7
12.8
58
173
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.1
12.6
71
250
Z3226
NOMESCO Finland
Physiotherapist
2.4
12.5
128
636
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
133.1
12.5
13
*
SPAT1324
SPAT
Screening procedure
2.7
12.4
95
405
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
12.0
12.4
22
19
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.7
12.3
35
65
K29.4
ICD-10 Finland
Chronic atrophic gastritis
5.9
12.3
34
61
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.4
12.3
44
106
XF404
NOMESCO Finland
Ambulatory ECG
3.0
12.3
75
279
UJD02
NOMESCO Finland
Gastroscopy
4.4
12.0
44
108
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
11.5
11
*
JDH05
NOMESCO Finland
Endoscopic polypectomy in duodenum
+∞
11.5
11
*
XF402
NOMESCO Finland
ECG with work load test
2.7
11.5
83
340
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.4
11.5
107
507
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
20.6
11.2
16
8
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
10.7
161
943
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
10.5
159
930
R4110
NOMESCO Finland
Physiotherapy
2.0
10.5
165
983
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
23.9
10.3
14
6
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
10.1
126
680
H01CB02
ATC
octreotide; parenteral
40.9
10.0
12
*
JAH01
NOMESCO Finland
Laparoscopy
4.1
9.7
37
95
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
9.7
73
306
N02AX02
ATC
tramadol; systemic, rectal
1.8
9.7
235
1623
P01AB01
ATC
metronidazole; oral, rectal
1.9
9.7
215
1441
WZC00
SPAT
NA
4.4
9.7
34
81
K22.1
ICD-10 Finland
Ulcer of oesophagus
6.6
9.7
24
38
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
9.5
111
580
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.5
9.5
43
129
2112X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Duodenum, jejunum and ileum[NEOPLASMA BENIGNUM ALIUD INTESTINI TENUIS, DUOD INC]
+∞
9.4
9
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.3
9.2
27
53
J01MA12
ATC
levofloxacin; systemic
2.1
9.1
112
600
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
9.1
90
438
JN4BD
NOMESCO Finland
Extensive body CT
2.4
9.1
82
378
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
19.0
9.0
13
7
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.2
8.9
33
83
C03CA01
ATC
furosemide; systemic
1.9
8.8
172
1096
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
8.8
55
208
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
8.7
49
171
JFA05
NOMESCO Finland
Endoscopic polypectomy in small intestine
50.9
8.7
10
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.7
8.7
24
44
R52.9
ICD-10 Finland
Pain, unspecified
2.7
8.5
60
242
A98
ICPC
Health maint/preventive medicine
0.5
8.5
394
4446
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.6
8.5
37
108
H02AB07
ATC
prednisone; oral
2.2
8.4
90
452
Z2446
NOMESCO Finland
Social worker
3.1
8.4
47
163
J01MA02
ATC
ciprofloxacin; systemic
1.8
8.4
211
1454
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
8.4
101
533
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
+∞
8.4
8
*
UKC02
NOMESCO Finland
Cystoscopy
2.1
8.3
97
508
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
17.5
8.1
12
7
K56.7
ICD-10 Finland
Ileus, unspecified
6.0
8.1
21
36
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.7
8.1
54
212
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
8.0
87
440
K92.1
ICD-10 Finland
Melaena
3.3
7.9
38
120
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.9
443
3894
B01AB05
ATC
enoxaparin; parenteral
1.8
7.9
177
1171
Z71.8
ICD-10 Finland
Other specified counselling
1.9
7.9
124
727
K29.1
ICD-10 Finland
Other acute gastritis
7.1
7.8
18
26
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
7.8
122
715
L01XE01
ATC
[U] imatinib; oral
45.7
7.7
9
*
3AC01
NOMESCO Finland
NA
12.1
7.6
13
11
189
Kela drug reimbursment
Imatinib
25.4
7.6
10
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
7.3
7.5
17
24
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
6.1
7.4
19
32
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
7.8
7.4
16
21
G44.2
ICD-10 Finland
Tension-type headache
2.2
7.4
76
373
U07.2
ICD-10 Finland
COVID-19, virus not identified
2.4
7.4
63
285
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
7.4
105
592
WX002
NOMESCO Finland
Sedation and analgesia
1.9
7.2
122
729
E34.0
ICD-10 Finland
Carcinoid syndrome
30.5
7.2
9
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
20.3
7.2
10
5
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.5
7.1
32
97
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
7.0
65
304
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
7.0
104
594
RD210
NOMESCO Finland
NA
6.5
7.0
17
27
N03AX16
ATC
pregabalin; oral
1.8
7.0
134
837
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
7.7
6.9
15
20
A02BC03
ATC
lansoprazole; oral
1.7
6.9
170
1149
K29.7
ICD-10 Finland
Gastritis, unspecified
3.8
6.9
27
73
K50.9
ICD-10 Finland
Crohn disease, unspecified
6.8
6.9
16
24
J45.1
ICD-10 Finland
Nonallergic asthma
2.6
6.8
48
196
JAH00
NOMESCO Finland
Laparotomy
4.4
6.8
23
54
WW500
NOMESCO Finland
Blood transfusion
3.4
6.8
31
95
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
6.8
154
1016
6402
FHL
Small bowel resection
40.6
6.8
8
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.7
6.7
46
183
R03AC03
ATC
terbutaline; inhalant
2.1
6.7
80
421
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
8.0
6.6
14
18
I20.90
ICD-10 Finland
Angina pectoris, unspecified
3.5
6.6
29
86
N06AB04
ATC
citalopram; systemic
1.8
6.6
122
750
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.6
6.5
27
77
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.4
6.4
52
229
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.5
6.4
28
83
M70.8
ICD-10 Finland
Other soft tissue disorders related to use, overuse and pressure
14.5
6.4
10
7
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
6.4
96
548
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
6.4
131
835
A07EA06
ATC
budesonide; oral, local oral
3.6
6.4
27
78
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
6.4
207
1505
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
6.3
69
347
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
6.3
40
151
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
11.2
6.3
11
10
J01DB01
ATC
cefalexin; oral
1.7
6.3
406
3532
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
18.3
6.3
9
5
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
27.0
6.2
8
*
JFA73
NOMESCO Finland
Excision of lesion of small intestine
27.0
6.2
8
*
K30
ICD-10 Finland
Functional dyspepsia
2.2
6.2
64
313
A03FA02
ATC
cisapride; oral, rectal
2.4
6.2
50
220
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
6.0
81
446
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.5
6.0
26
77
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
6.0
49
217
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
163
695
2.90
26.57
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
138
559
2.95
24.50
3.9
4.0
ug/l
6.1
34.2
1.22
118
474
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
262
1474
2.47
23.83
4.5
3.2
u/l
33.4
32.5
0.15
249
1400
(3022948) Iron [Moles/volume] in Serum or Plasma
166
765
2.67
22.87
3.8
2.2
umol/l
11.0
12.7
2.66
156
702
(3004789) Transferrin [Mass/volume] in Serum or Plasma
156
697
2.72
22.86
3.7
2.2
g/l
2.4
2.3
0.33
150
644
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
150
663
2.73
22.40
3.8
2.2
%
19.0
21.8
2.06
134
565
(3030467) Casts [#/volume] in Urine by Automated count
243
1357
2.40
22.04
5.0
3.2
e6/l
0.4
0.5
0.36
192
1023
(36304419) Bacteria [Presence] in Urine
238
1321
2.40
21.84
4.7
3.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
328
2128
2.32
20.50
7.4
6.1
%
8.4
8.7
0.76
310
1985
(3006504) Eosinophils/100 leukocytes in Blood
327
2122
2.31
20.38
7.2
5.8
%
2.8
2.8
0.02
311
1962
(3002032) Base excess in Venous blood by calculation
113
457
2.85
19.79
5.3
3.2
mmol/l
2.0
2.1
0.15
96
357
(3000330) Specific gravity of Urine by Test strip
78
255
3.39
19.68
5.1
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
186
965
2.39
19.45
3.3
3.0
mosm/kgh2o
520.2
551.6
1.10
162
832
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
370
2558
2.33
19.44
9.1
6.1
umol/l
11.6
11.3
0.20
360
2418
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
184
956
2.38
19.13
4.4
3.9
ng/l
58.0
254.1
2.58
150
780
(3018010) Neutrophils/100 leukocytes in Blood
325
2139
2.25
19.10
7.3
5.7
%
57.4
57.8
0.19
304
1991
(3002030) Lymphocytes/100 leukocytes in Blood
328
2171
2.25
18.95
7.3
6.0
%
27.5
27.2
0.21
310
2007
(3002582) Erythrocytes [#/volume] in Urine
249
1477
2.24
18.85
5.1
3.3
e6/l
28.4
107.1
1.06
205
1142
(3012544) pH of Venous blood
114
475
2.76
18.80
5.2
3.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
125
546
2.66
18.79
2.9
2.6
umol/l
11.1
8.3
0.46
113
474
(3022096) Basophils/100 leukocytes in Blood
315
2059
2.22
18.67
7.2
5.8
%
0.7
0.7
0.29
298
1910
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
69
216
3.51
18.60
4.2
3.2
u/ml
68.1
1794.6
1.28
57
186
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
104
418
2.83
18.34
3.5
3.1
ng/l
191.7
201.7
0.11
96
388
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
279
1757
2.18
17.93
5.0
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
272
1700
2.17
17.77
5.7
3.9
e6/l
167.6
85.8
0.40
209
1226
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
357
2491
2.21
17.49
9.2
6.2
mmol/l
1.2
1.2
0.18
333
2103
(42870588) Differential panel, method unspecified - Blood
251
1532
2.16
17.30
5.9
5.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
305
2036
2.10
16.31
12.0
9.6
e9/l
0.0
0.0
0.41
246
1665
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
246
1530
2.09
15.75
3.8
2.3
u/l
59.5
56.4
0.58
236
1405
(3024561) Albumin [Mass/volume] in Serum or Plasma
312
2133
2.05
15.27
7.3
4.4
g/l
34.9
35.2
0.27
300
1983
(3001604) Monocytes [#/volume] in Blood
324
2253
2.05
15.04
6.9
5.7
e9/l
0.6
0.6
0.40
272
1929
(1761482) Bacteria [#/volume] in Urine by Culture
49
141
3.71
14.93
4.3
4.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
325
2267
2.04
14.90
6.9
5.7
e9/l
0.0
0.0
0.00
273
1945
(3013115) Eosinophils [#/volume] in Blood
332
2340
2.04
14.71
7.6
5.9
e9/l
0.2
0.2
0.04
287
2039
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
302
2062
2.02
14.59
2.2
2.0
pmol/l
89.1
95.2
1.26
156
1022
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
150
791
2.23
14.50
3.9
3.0
e6/l
2.5
2.6
0.05
89
414
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
100
441
2.55
14.49
3.3
2.3
u/l
41.0
32.4
0.62
88
365
(3012095) Magnesium [Moles/volume] in Serum or Plasma
148
777
2.23
14.46
3.8
3.1
mmol/l
0.8
0.8
0.12
138
724
(3019198) Lymphocytes [#/volume] in Blood
327
2304
2.02
14.36
7.0
5.7
e9/l
1.9
1.9
0.03
282
2014
(3032080) INR in Blood by Coagulation assay
299
2044
2.00
14.29
11.0
9.5
inr
1.4
1.2
0.86
45
570
(3044640) Blood type and Crossmatch panel - Blood
237
1500
2.01
14.04
3.6
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
360
2646
2.02
13.77
12.0
9.1
e9/l
4.2
4.1
0.22
312
2307
(3000850) Epithelial cells [#/volume] in Urine
178
1022
2.09
13.74
4.0
2.6
e6/l
5.2
5.8
0.20
166
918
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
75
4.61
13.73
3.1
2.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
204
1236
2.03
13.56
3.3
2.1
mg/l
3.5
3.2
0.56
184
1044
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
155
849
2.14
13.50
3.7
2.7
e6/l
3.0
1.2
1.32
93
469
(3000991) Gas panel - Venous blood
91
397
2.55
13.44
7.2
7.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
456
3683
2.32
13.31
11.8
7.5
u/l
86.0
79.6
1.53
443
3431
(3020779) Urea [Moles/volume] in Serum or Plasma
91
401
2.52
13.15
9.7
6.1
mmol/l
11.2
9.9
0.84
86
378
(3003458) Phosphate [Moles/volume] in Serum or Plasma
123
624
2.25
12.92
7.6
4.6
mmol/l
1.0
1.0
0.01
114
565
(3013826) Glucose [Moles/volume] in Serum or Plasma
372
2802
1.99
12.82
6.2
4.6
mmol/l
6.9
6.7
1.24
355
2640
(4094501)
42
122
3.64
12.61
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
103
505
2.28
11.66
3.0
2.1
ug/g
161.2
135.3
0.37
89
389
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
92
443
2.29
10.82
2.5
2.0
g/l
0.2
0.2
1.34
83
415
(3001122) Ferritin [Mass/volume] in Serum or Plasma
273
1935
1.81
10.52
4.6
2.6
ug/l
103.3
131.2
2.34
261
1747
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
64
266
2.59
10.37
3.2
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
182
1152
1.86
10.06
2.7
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
184
1173
1.85
9.92
8.9
6.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
312
2332
1.77
9.77
4.9
4.0
estimate
0.0
0.0
0.50
19
412
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
82
393
2.27
9.72
4.3
3.4
ng/l
123.5
82.9
2.01
70
344
(3023368) Bacteria identified in Blood by Culture
204
1352
1.80
9.63
5.9
4.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
296
2186
1.76
9.61
5.3
3.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
59
4.21
9.07
5.8
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
304
2296
1.71
8.81
4.8
4.0
estimate
0.0
0.0
0.00
18
425
(3021601) Nitrite [Presence] in Urine by Test strip
305
2307
1.71
8.78
8.3
5.3
estimate
0.0
0.0
0.00
20
419
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
58
253
2.44
8.49
7.9
8.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
464
3992
1.98
8.29
32.6
16.6
%
37.3
39.2
3.28
300
2654
(3027801) Oxygen [Partial pressure] in Arterial blood
104
580
1.98
8.26
8.0
6.5
kpa
12.2
12.0
0.09
97
557
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
104
580
1.98
8.26
8.0
6.5
kpa
5.1
5.1
0.22
96
557
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
358
2856
1.71
8.23
3.9
3.1
u/l
58.7
50.0
0.77
339
2635
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
357
2.20
8.21
2.4
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
27
5.68
8.06
1.1
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
103
579
1.96
7.98
8.1
6.6
mmol/l
1.1
1.3
0.19
85
463
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
56
4.05
7.95
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
49
205
2.52
7.83
3.0
1.9
ug/l
5.1
3.2
0.27
39
182
(3019150) Specific gravity of Urine by Refractometry
158
1034
1.74
7.46
4.5
4.4
kg/l
1.0
1.0
2.35
73
140
(3016502) Oxygen saturation in Arterial blood
93
520
1.95
7.29
8.1
6.7
%
95.0
95.6
0.32
87
500
(3002385) Erythrocyte distribution width [Ratio]
435
3724
1.77
7.13
35.5
18.7
%
14.1
13.8
1.72
425
3645
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
27
5.29
7.00
1.2
1.9
%
14.3
14.0
—
6
11
(3037467) Urinalysis macro (dipstick) panel - Urine
389
3244
1.66
6.87
6.1
4.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
50
225
2.34
6.84
1.6
1.9
g/l
1.6
1.6
0.23
42
196
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
95
3.05
6.63
1.2
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
60
296
2.15
6.60
2.0
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
98
580
1.84
6.43
2.9
2.5
%
1.8
1.9
0.09
88
520
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
51
3.82
6.41
1.1
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
156
1063
1.65
6.19
2.5
1.6
mg/l
1.0
1.2
0.60
133
827
(3037522) Nuclear Ab [Titer] in Serum
97
580
1.81
6.14
1.4
1.3
titre
400.0
514.8
0.32
17
131
(3011412) CD3 cells [#/volume] in Blood
16
40
4.09
5.93
1.9
1.9
e9/l
1.2
1.1
—
9
21
(3007164) IgA [Mass/volume] in Serum or Plasma
129
845
1.69
5.92
1.5
1.5
g/l
2.4
2.5
0.16
79
483
(3018418) pH of Serum or Plasma
207
1525
1.57
5.89
4.7
3.7
ph
7.4
7.4
—
8
281
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
258
1999
1.54
5.85
2.7
2.2
nmol/l
80.1
78.5
0.42
241
1752
(3052851) Hemolysis interference index of Serum or Plasma
35
144
2.53
5.82
3.3
3.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
64
340
2.00
5.79
1.8
2.9
g/l
9.4
10.2
0.94
58
311
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
128
2.59
5.64
2.9
2.5
ug/min
10.2
116.2
2.76
26
74
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
53
3.48
5.35
1.1
1.2
u/ml
3.6
3.2
—
5
15
(3025941) Bacteria identified in Stool by Culture
49
243
2.11
5.33
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
145
1003
1.60
5.32
1.6
1.8
nmol/l
925.1
1217.0
4.76
122
739
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
499
4557
1.93
5.31
28.0
15.3
mg/l
25.4
24.4
0.29
432
3633
(3025159) Blasts/100 leukocytes in Blood
62
337
1.95
5.26
4.0
4.7
%
0.1
1.0
—
10
95
(3028026) IgM [Mass/volume] in Serum or Plasma
53
273
2.04
5.22
1.5
1.8
g/l
1.0
1.6
1.45
48
247
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
88
536
1.76
5.21
4.2
4.2
u/l
237.4
252.9
0.41
83
506
(3032773) Endomysium IgG Ab [Titer] in Serum
15
40
3.83
5.12
1.2
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
404
3503
1.56
5.12
5.5
4.3
mm/h
14.2
13.2
0.64
388
3207
(3015377) Calcium [Moles/volume] in Serum or Plasma
221
1697
1.50
5.01
4.2
3.4
mmol/l
2.3
2.4
0.54
196
1463
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
149
2.37
4.97
1.4
1.5
ug/g
279.8
276.6
0.04
23
90
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
61
3.19
4.96
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
96
609
1.70
4.92
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
150
2.35
4.90
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
169
1231
1.54
4.90
1.7
1.6
nmol/l
20.3
21.2
0.40
155
1022
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
282
2285
1.48
4.84
7.7
5.4
mmol/l
1.2
1.2
1.36
259
2046
(4211845)
10
20
5.07
4.79
5.5
3.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
52
3.34
4.78
1.1
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
34
152
2.32
4.76
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
161
2.25
4.60
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
87
547
1.70
4.60
1.5
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
25
4.47
4.58
1.5
3.6
u/l
183.5
209.7
0.61
11
25
(3021440) Promyelocytes/100 leukocytes in Blood
63
362
1.83
4.52
4.5
4.6
%
0.0
0.2
3.28
12
115
(3041096) Erythrocytes [Presence] in Urine by Automated
166
1225
1.51
4.47
5.6
3.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
150
2.28
4.46
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
100
2.57
4.44
1.1
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
48
254
1.97
4.41
3.1
3.0
e6/l
0.3
0.2
0.14
48
244
(3017181) Myelocytes/100 leukocytes in Blood
66
388
1.80
4.40
4.3
4.4
%
0.2
0.9
3.97
12
130
(3007853) Bacteria identified in Skin by Aerobe culture
84
530
1.69
4.38
2.3
1.7
—
—
—
0
0
(3013512) EKG study
195
1498
1.46
4.26
6.3
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
30
134
2.31
4.23
1.4
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
19
68
2.86
4.16
1.1
1.2
—
66.5
—
0
6
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
155
2.20
4.14
2.6
2.2
u/ml
0.4
0.4
0.07
19
86
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
203
2.05
4.13
1.6
2.2
g/l
10.0
10.4
0.20
35
175
(3026008) Bacteria identified in Urine by Culture
204
1598
1.44
3.97
3.7
3.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
215
1.98
3.89
1.6
2.1
g/l
3.4
3.7
0.69
23
160
(3014007) Fractional oxyhemoglobin in Arterial blood
54
311
1.82
3.87
9.9
7.8
%
94.1
94.2
0.03
54
306
(40760892) CBC W Ordered Manual Differential panel - Blood
131
946
1.50
3.85
5.8
4.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
87
1266
0.63
3.85
4.5
4.3
estimate
0.0
0.0
0.00
19
408
(3042936) Bacteria identified in Isolate by Culture
103
706
1.56
3.84
2.6
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
216
1.97
3.84
1.6
2.1
g/l
7.1
7.6
0.70
23
164
(4306422)
15
49
3.12
3.83
1.1
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
29
3.85
3.82
1.5
1.1
—
—
—
0
0
(4035726)
71
445
1.68
3.80
1.5
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
201
1582
1.42
3.77
3.1
3.1
ng/l
1895.6
1295.9
0.64
182
1357
(3034770) Mitochondria Ab [Titer] in Serum
26
115
2.32
3.77
1.3
1.2
—
656.0
—
0
5
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
585
1.60
3.74
2.2
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
25
4.05
3.71
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
380
0.38
3.65
4.6
4.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
137
2.18
3.62
1.3
1.6
iu/ml
0.1
0.1
—
10
27
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
401
3575
1.44
3.57
4.6
4.0
pmol/l
14.5
14.9
3.16
377
3187
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
63
2.75
3.52
1.1
1.2
u/ml
2.4
4.8
—
7
24
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
216
1.92
3.50
1.6
2.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
14
5.78
3.35
1.0
2.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
14
5.78
3.35
1.4
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
146
1105
1.44
3.34
3.5
3.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
65
2.67
3.33
1.3
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
68
437
1.63
3.31
2.2
2.7
e9/l
72.5
71.7
0.06
50
340
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
145
1102
1.43
3.23
1.7
1.7
pmol/l
76562982.1
6455717.2
0.44
128
883
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
589
1.54
3.21
2.2
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
10
28
3.62
3.21
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
159
1232
1.41
3.17
3.5
2.7
umol/l
7964.7
8288.6
0.02
143
1038
(3013139) Helicobacter pylori Ag [Presence] in Stool
48
284
1.76
3.17
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
61
2.67
3.16
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
105
2.24
3.13
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
105
2.24
3.13
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
966
1.44
3.11
1.3
1.2
u/ml
0.6
1.8
1.65
40
254
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
31
160
1.99
3.11
1.3
1.4
g/l
1.3
1.2
0.82
26
151
(3000494) Fungus identified in Specimen by Culture
83
569
1.54
3.09
1.7
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
88
2.32
2.97
3.4
2.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
17
4.76
2.93
4.7
3.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
76
2.41
2.92
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
30
3.38
2.92
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
70
2.47
2.90
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
109
2.16
2.88
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
216
1782
1.35
2.88
5.6
4.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
13
5.44
2.87
1.1
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
210
1.82
2.82
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
654
0.58
2.81
3.6
4.7
%
34.3
32.2
0.47
25
417
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
54
2.63
2.72
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
644
0.59
2.65
7.4
7.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
110
824
1.42
2.63
2.2
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
83
592
1.47
2.57
1.2
1.3
—
—
—
0
0
(4268621)
12
44
2.77
2.56
1.8
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
96
2.12
2.46
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
505
4801
1.57
2.43
31.6
17.8
mmol/l
139.7
139.7
0.09
497
4672
(3051651) Icteric interference index of Serum or Plasma
10
34
2.98
2.42
5.5
3.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
506
4815
1.57
2.40
31.6
17.9
mmol/l
3.9
4.0
2.49
496
4681
(3022806) Fractional oxyhemoglobin in Capillary blood
0
67
0.00
2.40
0.0
2.0
—
89.5
—
0
67
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
77
2.25
2.40
1.3
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
126
981
1.37
2.39
3.8
3.0
mmol/l
2.5
2.5
0.48
109
868
(3025130) Human papilloma virus identified in Specimen
11
40
2.79
2.38
1.4
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
8
6.29
2.37
1.0
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
454
4238
1.39
2.34
5.7
4.9
mu/l
1.9
2.3
0.61
436
3808
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
119
1.97
2.34
1.1
1.3
—
—
—
0
0
(3000492) Spirometry study
57
385
1.54
2.30
1.6
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
72
2.26
2.29
2.4
2.6
—
764.5
—
0
6
(4062490)
10
36
2.81
2.21
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
68
481
1.47
2.21
1.8
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
463
4352
1.38
2.15
23.4
14.4
ml/min/173m2
74.7
76.5
1.07
421
3556
(3000475) Leukocytes [#/volume] in Synovial fluid
23
123
1.91
2.14
2.0
1.6
e6/l
3705.2
17877.3
1.89
18
89
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
275
2421
1.27
2.07
2.9
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
420
1.48
2.06
1.5
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
15
4.03
2.04
4.3
4.5
%
43.7
48.9
—
6
15
(3024928) Oxygen saturation in Venous blood
21
111
1.93
2.03
2.2
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
26
3.11
2.02
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
495
4718
1.45
2.01
25.4
14.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
32
2.84
2.01
2.7
2.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
11
4.58
1.94
1.0
1.2
%
118.6
95.5
—
5
11
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
11
4.58
1.94
1.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
38
244
1.60
1.93
1.1
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
99
1.95
1.92
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
385
1.48
1.90
1.5
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
221
1916
1.25
1.84
2.4
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
108
1.88
1.84
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
288
1.53
1.83
3.8
3.4
mmol/l
2.4
1.8
0.48
33
217
(3047189) Immunofixation for 24 hour Urine
7
23
3.07
1.80
1.1
1.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
26
154
1.72
1.79
1.5
1.7
—
191.4
—
0
7
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
30
2.69
1.73
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
30
2.69
1.73
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
505
4853
1.44
1.73
16.2
11.0
u/l
26.0
24.6
1.08
499
4657
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
61
2.16
1.72
1.2
1.3
nmol/l
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
792
1.32
1.69
1.3
1.3
iu/ml
28.3
37.5
0.59
26
260
(3023183) Ammonium ion [Moles/volume] in Plasma
19
104
1.86
1.69
1.8
2.7
umol/l
33.4
34.6
0.06
14
86
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
49
2.27
1.64
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
16
84
1.93
1.61
3.4
1.7
%
58.5
57.8
0.04
16
84
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
45
315
1.47
1.58
2.0
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
20
3.02
1.58
1.3
1.1
mmol/l
6.0
7.0
—
6
20
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
20
3.02
1.58
2.5
1.6
ug/l
34.0
59.9
—
6
20
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
51
2.18
1.51
5.4
3.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
21
2.88
1.51
1.2
3.0
u/ml
435.0
1007.9
—
6
21
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
38
2.39
1.46
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
94
756
1.29
1.43
1.4
1.3
u/ml
12.0
13.4
0.07
44
271
(3019060) Gas panel - Arterial blood
48
349
1.41
1.40
8.7
4.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
29
2.43
1.39
1.0
1.2
u/l
10.6
25.1
—
7
23
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
220
1952
1.21
1.39
4.3
4.0
ng/l
26.3
54.9
1.01
160
1450
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
168
1.57
1.34
1.7
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
45
328
1.40
1.31
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
43
2.11
1.31
1.6
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
24
2.52
1.30
1.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
26
170
1.56
1.28
2.7
2.2
ug/l
354.5
534.9
0.25
26
159
(3003181) Sodium [Moles/volume] in Urine
17
100
1.72
1.24
1.5
1.3
mmol/l
61.3
61.5
—
10
85
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
36
2.24
1.24
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
19
2.65
1.22
1.0
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
133
1.60
1.19
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
150
1.56
1.16
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
453
4341
1.24
1.15
7.9
6.3
mmol/mol
41.2
40.4
1.09
437
3984
(3037756) Immunofixation for Serum or Plasma
20
127
1.60
1.13
1.1
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
31
2.27
1.10
1.3
1.5
%
9.7
9.9
—
7
31
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
7
31
2.27
1.10
1.0
1.2
u/l
68.3
78.7
—
7
26
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
21
2.39
1.09
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
21
2.39
1.09
7.2
5.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
41
1.96
1.09
2.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
203
1.45
1.07
1.8
2.2
g/l
3.4
3.2
0.32
23
163
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
74
1.77
1.07
1.8
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
81
665
1.26
1.07
32.4
25.4
inr
1.3
1.3
—
5
91
(21494890) Protein electrophoresis panel - 24 hour Urine
10
52
1.94
1.06
1.2
2.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
46
1.97
1.04
1.1
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
22
2.28
1.03
1.2
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
60
1.85
1.03
2.7
1.4
ug/l
14.6
16.1
0.39
11
60
(21494755) Public health laboratory ask at order entry panel
16
250
0.63
1.03
1.2
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
140
1.52
0.99
1.8
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
45
346
1.33
0.99
4.0
4.5
%
0.2
0.5
—
6
93
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
36
1.96
0.97
1.0
1.4
—
24.0
—
0
5
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
50
1.81
0.97
2.6
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
141
1.51
0.96
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
85
1.66
0.95
1.1
1.3
miu/ml
135.9
243.3
—
5
36
(4281824)
9
51
1.78
0.95
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
37
1.90
0.94
1.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
27
2.24
0.93
3.7
1.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
25
176
1.44
0.92
2.4
3.8
mg/l
51.8
90.0
0.49
25
139
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
25
176
1.44
0.92
2.4
3.8
mg/l
49.3
47.1
0.03
25
140
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
110
1.56
0.91
2.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
63
1.76
0.90
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
299
0.69
0.89
2.2
1.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
512
5004
1.29
0.88
40.2
22.5
fl
91.2
91.5
0.66
505
4921
(3007461) Platelets [#/volume] in Blood
512
5005
1.29
0.87
40.3
22.6
e9/l
243.9
247.6
0.64
500
4864
(3035941) MCH [Entitic mass]
512
5005
1.29
0.87
40.1
22.5
pg
30.3
30.3
0.47
505
4922
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
64
1.73
0.86
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
64
1.73
0.86
1.5
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
512
5006
1.29
0.85
40.2
22.6
e12/l
4.3
4.4
5.19
498
4845
(3010813) Leukocytes [#/volume] in Blood
512
5006
1.29
0.85
40.2
22.6
e9/l
6.9
6.7
0.86
497
4844
(3000963) Hemoglobin [Mass/volume] in Blood
512
5008
1.28
0.83
40.5
22.7
g/l
129.3
133.6
8.36
507
4922
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
65
1.71
0.83
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
65
1.71
0.83
1.1
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
32
1.88
0.82
4.3
3.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
14
89
1.59
0.82
1.1
1.1
u/l
69.7
23.0
0.49
14
72
(1761868) Lipid panel - Serum or Plasma
161
1450
1.16
0.81
4.2
3.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
216
1.36
0.80
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
24
173
1.40
0.80
2.4
3.8
—
2.0
—
0
19
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
151
1355
1.16
0.79
5.6
5.2
ug/l
2.7
3.3
0.28
136
1199
(3017732) Neutrophils [#/volume] in Blood
38
297
1.30
0.77
2.4
3.0
e9/l
4.1
4.0
0.09
28
219
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
354
3372
1.14
0.75
4.2
4.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
36
281
1.30
0.74
1.0
1.2
iu/ml
166.9
128.2
0.21
16
112
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
24
2.09
0.74
1.0
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
24
2.09
0.74
1.0
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
55
454
1.23
0.73
1.6
2.5
ug/l
4.4
6.9
1.34
49
395
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
468
4549
1.18
0.73
5.2
4.9
mmol/l
6.2
6.0
2.39
448
4090
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
39
309
1.28
0.73
2.1
2.6
—
11.2
—
0
8
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
39
1.80
0.72
1.0
1.5
—
290.0
—
0
5
(3023419) Bacteria identified in Sputum by Culture
10
60
1.68
0.72
6.2
2.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.71
1.4
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.71
1.4
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
41
1.72
0.70
1.9
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
93
1.52
0.70
1.9
1.6
—
—
—
0
0
(44813793)
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
42
513
0.80
0.66
4.3
4.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
78
1.55
0.66
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
130
1.40
0.62
1.5
4.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.2
—
44.7
—
0
15
(3045414) Leukocytes [Presence] in Urine
14
197
0.70
0.60
1.7
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
114
1.42
0.59
2.1
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
175
1.33
0.59
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
64
1.57
0.59
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
64
1.57
0.59
1.5
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
8
53
1.52
0.58
1.3
1.0
—
2.0
—
0
20
(44790048)
8
53
1.52
0.58
1.4
1.6
—
—
—
0
0
(44790047)
8
53
1.52
0.58
1.4
1.6
—
—
—
0
0
(44790049)
8
53
1.52
0.58
1.4
1.6
—
—
—
0
0
(44806118)
8
53
1.52
0.58
1.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
116
0.60
0.58
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
124
1.38
0.56
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
65
1.55
0.56
1.5
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
9
60
1.51
0.54
1.0
1.1
—
74.4
—
0
9
(40761535) Cells panel - Urine sediment
33
403
0.81
0.54
4.5
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
61
1.48
0.54
1.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
39
1.54
0.53
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
38
316
1.22
0.51
4.0
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
65
1.39
0.51
1.1
2.1
pg
31.6
32.2
—
9
65
(3004588) Protein electrophoresis panel - Serum or Plasma
45
382
1.19
0.49
1.7
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
1278
0.89
0.49
1.7
1.6
mmol/l
1.4
1.3
0.67
101
1053
(3022313) Gas panel - Capillary blood
29
235
1.25
0.49
3.3
3.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
109
0.64
0.49
2.3
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
438
0.83
0.46
2.2
1.7
%
1.4
1.5
0.92
32
375
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.1
1.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
77
1.44
0.46
1.5
1.5
mu/l
465.6
277.1
0.93
11
71
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
501
0.85
0.45
4.0
3.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
5
31
1.62
0.43
1.4
1.2
u/ml
0.1
1.3
—
5
17
(3021788) Differential panel - Synovial fluid
12
87
1.39
0.42
1.3
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
70
1.44
0.42
1.5
1.7
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
15
0.00
0.41
0.0
5.9
—
26.2
—
0
15
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.4
—
2.4
—
0
7
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
79
1.40
0.41
1.5
1.7
nmol/l
39.6
43.1
0.16
11
73
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
1.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
260
1.20
0.40
1.3
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
1.6
—
0
13
(3020682) Albumin/Creatinine [Ratio] in Urine
166
1561
1.09
0.40
4.0
3.9
mg/mmol
16.9
8.3
0.76
109
959
(40768793) Breast Pathology biopsy report
10
137
0.72
0.39
1.3
1.3
—
—
—
0
0
(4034850)
19
151
1.27
0.39
13.1
11.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
147
0.74
0.37
2.2
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
116
0.69
0.37
2.0
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
76
0.65
0.36
1.8
3.2
e9/l
2.6
4.3
—
5
76
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
42
1.43
0.35
1.0
1.5
—
25.0
—
0
7
(3049717) Cytology report of Urine Cyto stain
24
199
1.22
0.35
2.8
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
80
0.62
0.35
1.8
3.7
%
54.4
58.9
—
5
80
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
43
1.40
0.35
1.7
1.5
u/l
12.9
38.6
—
6
34
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
444
4358
1.09
0.35
4.4
4.2
mmol/l
1.3
1.3
0.74
419
3911
(3009508) Creatinine [Moles/volume] in Urine
142
1508
0.92
0.34
3.4
3.1
mmol/l
6.7
7.0
0.57
125
1239
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
91
1.33
0.34
1.0
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
45
1.34
0.34
1.3
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
84
772
1.10
0.33
2.7
3.1
ug/l
0.8
0.8
0.07
66
525
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.2
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
89
0.67
0.33
4.8
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
47
1.28
0.32
1.2
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
83
1.33
0.32
1.8
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.1
1.9
—
—
—
0
0
(4010399)
41
365
1.13
0.28
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
66
1.22
0.27
1.5
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
67
1.20
0.26
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.5
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
72
0.69
0.26
1.2
1.3
u/l
13.2
11.5
—
5
57
(1616796) Gas panel - Central venous blood
12
96
1.26
0.24
4.2
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.5
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
40
1.25
0.22
1.0
1.1
—
1.0
—
0
7
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
201
1.15
0.21
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
6.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
7.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.2
1.8
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
0.6
—
0
9
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
109
1.20
0.18
1.8
1.6
iu/l
1.9
5.2
—
5
34
(3012516) Albumin [Mass/volume] in Urine
153
1478
1.05
0.17
3.5
3.2
mg/l
2261.0
184.5
1.47
98
919
(3028300) Cannabinoids [Presence] in Urine
5
69
0.72
0.17
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
69
0.72
0.17
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
69
0.72
0.17
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
19
168
1.14
0.16
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
73
1.10
0.15
1.4
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
202
0.89
0.14
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
469
4654
1.05
0.13
5.5
5.3
mmol/l
2.6
2.7
0.69
444
4218
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
41
384
1.07
0.13
2.7
2.7
ml/min/173m2
61.3
63.4
0.17
24
162
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
659
1.05
0.12
1.6
1.4
—
—
—
0
0
(3020891) Body temperature
18
199
0.90
0.11
14.1
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
115
1117
1.04
0.11
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
136
0.88
0.11
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
186
0.91
0.09
1.8
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
55
1.09
0.09
1.2
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
454
4514
1.03
0.08
4.8
4.6
mmol/l
1.4
1.5
4.51
431
4083
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
72
0.83
0.07
1.0
1.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
29
274
1.06
0.07
1.3
1.4
—
44.2
—
0
15
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
89
1.13
0.07
1.1
1.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
11
100
1.10
0.05
3.9
2.5
%
15.8
15.7
0.03
11
45
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
221
0.95
0.04
1.6
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
456
4544
1.02
0.04
4.8
4.7
mmol/l
4.5
4.6
1.44
435
4140
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
115
1.04
0.00
1.3
1.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
135
0.96
0.00
1.8
2.1
mg/l
12.6
13.0
0.07
13
124
(3037121) Protein [Mass/volume] in Urine
18
175
1.03
0.00
3.8
2.9
g/l
0.4
0.2
0.30
13
55
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
445
1.01
0.00
1.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
122
0.98
0.00
1.3
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
151
0.99
0.00
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
199
1.01
0.00
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
201
0.99
0.00
2.0
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
108
1081
1.00
0.00
5.0
4.5
%
23.0
21.0
0.71
60
524
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
6.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
73
0.96
0.00
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
91
0.99
0.00
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
59
0.85
0.00
1.8
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
59
0.85
0.00
4.0
7.1
mmol/l
6.1
6.6
—
5
47
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
61
0.98
0.00
2.2
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
65
0.92
0.00
3.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.2
—
0.3
—
0
5
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
2.6
—
0.9
—
0
7
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.6
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_SMALL_INTESTINE_OTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_SMALL_INTESTINE_OTH | 1.31 [1.14, 1.51] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.472 |
During the follow-up period (1.1.1998 — 31.12.2019), 383 out of 1599 females with CD2_BENIGN_SMALL_INTESTINE_OTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_SMALL_INTESTINE_OTH | 1.317 [1.13, 1.54] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 352 out of 1120 males with CD2_BENIGN_SMALL_INTESTINE_OTH died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_SMALL_INTESTINE_OTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.148% | 0.234% |
| 5 | 0.834% | 1.488% |
| 10 | 2.109% | 3.955% |
| 15 | 3.974% | 7.041% |
| 20 | 6.921% | 11.979% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SMALL_INTESTINE_OTH – Benign neoplasm: Other and unspecified parts of small intestine
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data